By Matt Chiappardi ( June 10, 2013, 9:18 PM EDT) -- An investor in medical device giant Baxter International Inc. hit 11 members of the company's board with a derivative suit Monday, claiming they didn't do enough to investigate fraud accusations connected to a $588 million infusion pump recall and claims that it manipulated the blood plasma market by swallowing up competitors....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.